LBTSF.US Almirall S.A

Healthcare Pharmaceuticals USA Stocks
15.35 USD
Close of Nov 15, 2026
15.35 15.47
Market cap
USD 3.34B
P/E
61.4x
P/B
1.67x
ROE
5.2%
Dividend yield
1.36%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is LBTSF.US undervalued?

Graham number
Price15.35
Graham value7.19
Premium113.4%

LBTSF.US trades 113.4% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Almirall S.A fundamental analysis

No fundamental analysis for Almirall S.A yet.

Almirall S.A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Almirall S.A

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism, anti-infective for systemic use, cardiovascular system, dermatological, genito urinary syst…

Full company profile